Here’s Why Madison Large Cap Fund Sold Elevance Health (ELV) in Q3

5 days ago 5

Soumya Eswaran

Tue, November 11, 2025 astatine 6:57 AM CST 2 min read

Madison Investments, an concern advisor, released its “Madison Large Cap Fund” third-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The money decreased 2.2% successful the 3rd 4th compared to an 8.1% summation for the S&P 500 Index. The existent marketplace absorption connected short-term profits led the money to underperform the benchmark considerably successful the quarter. In addition, delight cheque the fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its third-quarter 2025 capitalist letter, Madison Large Cap Fund highlighted stocks specified arsenic Elevance Health, Inc. (NYSE:ELV). Elevance Health, Inc. (NYSE:ELV) is simply a wellness benefits company. The one-month instrumentality of Elevance Health, Inc. (NYSE:ELV) was -13.32%, and its shares mislaid 26.43% of their worth implicit the past 52 weeks. On November 10, 2025, Elevance Health, Inc. (NYSE:ELV) banal closed astatine $303.78 per share, with a marketplace capitalization of $67.512 billion.

Madison Large Cap Fund stated the pursuing regarding Elevance Health, Inc. (NYSE:ELV) successful its 3rd 4th 2025 capitalist letter:

"During the quarter, we besides sold 2 comparatively tiny holdings successful Elevance Health, Inc. (NYSE:ELV) and Liberty Broadband. Elevance is the nation’s second-largest managed attraction provider. While we proceed to presumption the absorption squad arsenic beardown operators, the manufacture outlook has go much challenging crossed some Medicare Advantage and authorities Medicaid programs. Elevance’s standard and diverseness of operations, including an in-house connected attraction operation, person helped blunt the interaction of caller increases successful aesculapian costs. However, we present judge that the concern volition look a longer roadworthy to recovery."

Elevance Health (ELV) Drops 18.66% After Dismal Q2 Earnings

Elevance Health, Inc. (NYSE:ELV) is not connected our database of 30 Most Popular Stocks Among Hedge Funds. As per our database, 67 hedge money portfolios held Elevance Health, Inc. (NYSE:ELV) astatine the extremity of the 2nd quarter, which was 75 successful the erstwhile quarter. In Q3 2025, Elevance Health, Inc. (NYSE:ELV) reported $50.1 cardinal of operating revenue, an summation of 12% year-over-year. While we admit the imaginable of Elevance Health, Inc. (NYSE:ELV) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

In another article, we covered Elevance Health, Inc. (NYSE:ELV) and shared PBCM Concentrated Value Strategy's views connected the company. In addition, delight cheque retired our hedge money capitalist letters Q3 2025 page for much capitalist letters from hedge funds and different starring investors.